BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
1821 results:

  • 1. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.
    Zhang Y; Zhang H; Xu H; Wang Y; Feng L; Yi F
    World J Surg Oncol; 2024 May; 22(1):122. PubMed ID: 38711095
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
    Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
    [No Abstract]    [Full Text] [Related]  

  • 3. The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy.
    Du J; Zhang E; Huang Z
    Front Immunol; 2024; 15():1358306. PubMed ID: 38665910
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma.
    Zhu M; Jin M; Zhao X; Shen S; Chen Y; Xiao H; Wei G; He Q; Li B; Peng Z
    BMC Med; 2024 Apr; 22(1):165. PubMed ID: 38637772
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long noncoding RNA small nucleolar RNA host genes as prognostic molecular biomarkers in hepatocellular carcinoma: A meta-analysis.
    Huang M; Zhao Z; Yang L
    Cancer Med; 2024 Apr; 13(8):e7200. PubMed ID: 38634194
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
    Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
    Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract cancers (BTC) at high risk for recurrence: PURITY study.
    Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; Sottotetti E; Martinetti A; Busset MDD; Sposito C; Di Bartolomeo M; Pietrantonio F; de Braud F; Mazzaferro V
    BMC Cancer; 2024 Apr; 24(1):436. PubMed ID: 38589856
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
    Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
    Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic genomic alterations in patients undergoing liver resection for hepatocellular carcinoma.
    Nordkild SB; Ahlborn LB; Yde CW; Kugler JM; Klubien J; Akdag D; Willemoe GL; Nielsen SD; Pommergaard HC
    Mol Biol Rep; 2024 Mar; 51(1):450. PubMed ID: 38536546
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
    Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
    World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic PET [
    Chiu KWH; Tan KV; Yang X; Zhu X; Shi J; Chiang CL; Chan L; Hui Y; Khong PL; Man K; Wong JWH
    Cancer Imaging; 2024 Mar; 24(1):42. PubMed ID: 38520026
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Effectiveness of minimally invasive surgery in the treatment of pancreatic acinar cell carcinoma].
    Tao M; Yuan CH; Ma CL; Jiang B; Li L; Wang HY; Xiu DR
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):950-955. PubMed ID: 38514344
    [No Abstract]    [Full Text] [Related]  

  • 13. Vibration-Controlled Transient Elastography Scores to Predict liver-Related Events in Steatotic liver Disease.
    Lin H; Lee HW; Yip TC; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng MH; Hagström H; Boursier J; Calleja JL; Goh GB; Chan WK; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan JG; Castéra L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; de Saint-Loup M; Llop E; Teh KK; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS; Canivet CM; Romero-Gomez M; Kim SU; Wong VW;
    JAMA; 2024 Apr; 331(15):1287-1297. PubMed ID: 38512249
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis.
    Anouti A; Seif El Dahan K; Rich NE; Louissaint J; Lee WM; Lieber SR; Arab JP; Zhang BY; Patel MJ; Thimphittaya C; Díaz LA; Gregory DL; Kozlitina J; VanWagner LB; King AC; Mitchell MC; Singal AG; Cotter TG
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497931
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study.
    Varzaru B; Iacob RA; Bunduc S; Manea I; Sorop A; Spiridon A; Chelaru R; Croitoru A; Topala M; Becheanu G; Dumbrava M; Dima S; Popescu I; Gheorghe C
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474101
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A nomogram for predicting liver metastasis in patients with gastric gastrointestinal stromal tumor.
    Ruan J; He Y; Li Q; Jiang Z; Liu S; Ai J; Mao K; Dong X; Zhang D; Yang G; Gao D; Li Z
    J Gastrointest Surg; 2024 May; 28(5):710-718. PubMed ID: 38462423
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Zhang Q; Wei T; Jin W; Yan L; Shi L; Zhu S; Bai Y; Zeng Y; Yin Z; Yang J; Zhang W; Wu M; Zhang Y; Peng G; Roessler S; Liu L
    J Hepatol; 2024 Feb; 80(2):293-308. PubMed ID: 38450598
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.
    Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H
    Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Analysis of the efficacy and safety of hepatic arterial infusion chemotherapy for unresectable hepatitis B-related intrahepatic cholangiocarcinoma].
    He MR; Zheng ZK; Wu TQ; Chen MS; Zhou ZG
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):309-315. PubMed ID: 38432672
    [No Abstract]    [Full Text] [Related]  

  • 20. [Surgical treatment and prognosis analysis of hilar cholangiocarcinoma].
    Li XC; Li CX; Zhang H; Cheng F; Zhang F; Pu LY; Zhang CY; Wang K; Kong LB; Qian XF; Li DH; Lu WX; Wang P; Yao AH; Bai JF; Wu XF; Chen RX; Wang XH
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):290-301. PubMed ID: 38432670
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 92.